Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NexLife vs Nirwana Health

NexLife
Graded #139

Higher grade

vs+2.299999999999997
Nirwana Health
Graded #186

Lower grade

The verdict

NexLife takes it — 68.7/100 to 66.4/100.

NexLife grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNexLife +1
71
70
Dose & formulationNirwana Health +11
64
75
Clinical oversightNexLife +12
89
77
Labs & monitoringNexLife +1
53
52
FulfillmentEven
67
67
Contract termsNexLife +22
55
33
NexLife · left barNirwana Health · right bar

The numbers

MetricNexLifeNirwana Health
WeighScore68.7/10066.4/100
GradeCC
Scorecard rank#139#186
Semaglutide$165/mo (compounded)$149/mo (compounded)
Tirzepatide$215/mo (compounded)$229/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
NexLife

Graded #139 · C

Strengths

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset

Where it loses points

  • State availability not publicly disclosed
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity
  • Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
Nirwana Health

Graded #186 · C

Strengths

  • Offers compounded semaglutide and tirzepatide as both weekly injections and oral tablets
  • Transparent, published pricing with month-to-month, quarterly, and 6-month plans and no membership fee
  • Multi-month plans cut the per-month cost sharply (semaglutide as low as $99/mo, tirzepatide as low as $133/mo)
  • Advertises a $50-off code (LOOSE50) and covers weight loss plus hair, sexual-wellness, and longevity care
  • Also lists a retatrutide option and custom dosing plans for higher needs

Where it loses points

  • Prescribing medical group and compounding pharmacy are not named on the site
  • States of operation are not published; confirm eligibility during intake
  • Says it is 'LegitScript certified' but no verifiable seal is shown, so the claim is unconfirmed
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard